A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer
Clinical trial NCT02244463 · COMPLETED
Trial details
- NCT number
- NCT02244463
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2022-04-28
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.